Project Grant R15AI191202
Award Date
6/20/25
Completion Date
5/31/28
Dollars Obligated
$418K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Boise, ID 83725, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $158,260.00 to the University of Virginia to investigate the role of enteric glial cells (EGCs) in the pathogenesis of multiple sclerosis (MS). The project aims to characterize T cell responses against EGCs in an experimental autoimmune encephalomyelitis (EAE) model of MS and assess the impact of EGC ablation on disease onset and severity. This...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $427,627 to The University of Iowa to investigate how gamma herpesvirus (GHV) infection impacts B cell-dependent interactions that drive autoimmune demyelinating disease in a mouse model of multiple sclerosis (MS). The research aims to determine how GHV infection, such as Epstein-Barr virus, affects B cells'...
This Project Grant award of $305,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of stem-like T cells in multiple sclerosis (MS) disease progression. The key objectives are to: Rigorously test the hypothesis that a continuing stemness and differentiation of CD4+ T stem cells results in functional and transcriptomic diversification under evolving...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), with CFDA Number 93.213 - Research and Training in Complementary and Integrative Health, provides $863,500 to Rutgers, The State University of New Jersey to research the effect of dysbiotic gut microbiota on the transport of short-chain fatty acids (SCFAs) and its relevance to autoimmune disorders. The key objectives are to elucidate the mechanism by which gut dysbiosis impacts SCFA absorption and...
This $894,552 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the University of Nevada, Las Vegas to probe the effect of a high-fat/high-protein diet on Clostridioides difficile infection. Specifically, the researchers will examine how such a diet impacts inflammation, intestinal permeability, and the gut microbiome before and after antibiotic...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $180,310 to the University of Oklahoma Health Sciences Center to conduct research on the interactions between Clostridioides difficile toxin B (TcdB) and the host cell surface proteoglycan CSPG4. The overarching goal is to understand how CSPG4 is used by the hypervirulent TcdB2 isotype to promote the pathologies...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $754,446 to the University of Tennessee Health Science Center to develop microbiome-sparing antibacterials for the treatment of Clostridioides difficile infection (CDI). The key objectives are to optimize and expand the structure-activity relationship (SAR) of lead CDFabK inhibitor compounds, identify novel CDFabK...
The National Science Foundation (NSF) awarded a $400,000 Project Grant to Boise State University to study the mechanisms governing the formation and stability of species-rich microbial communities. The funding is provided through the NSF's Integrative Activities program (CFDA 47.083), which supports activities that build capacity for science and engineering and broaden participation in research and education. The key objectives of this 5-year project are to characterize the environmental factors...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $224,807 to the University of California, Irvine (UCI) to conduct research on identifying and engineering microbial enzymes that can modulate peptidoglycan (PG) metabolite levels in the gut microbiome. The goals are to discover highly active, secreted, and stable PG-degrading enzymes (Aim 1) and develop genetic tools...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,014,302 to Montana State University to conduct research on the role of phage FBB-1 in the horizontal gene transfer and infection dynamics of the Lyme disease spirochete Borrelia burgdorferi. The research aims to: 1) measure horizontal gene transfer between B. burgdorferi strains in ticks, 2) define the...